Extracorporeal Membrane Oxygenation Market Size, Segments, and Trends by 2028
Extracorporeal Membrane Oxygenation Market: Size and Share
-
CAGR (2023 - 2031)3.10% -
Market Size 2023
US$ 0.58 Billion -
Market Size 2031
US$ 0.74 Billion
Market Dynamics
- Growing Adoption of ECMO in Lung Transplantation Procedures Favors the Market Growth
- Surging Product Developments and Approvals
- Increasing Survival Rates with ECMO Creates Significant Opportunities in the Market
Market Segmentation
Modality - Venoarterial extracorporeal membrane oxygenation
- Venovenous extracorporeal membrane oxygenation
- Arteriovenous extracorporeal membrane oxygenation
Application - Respiratory and Cardiology
Age Group - Adults
- Pediatrics
- Neonates
Extracorporeal Membrane Oxygenation Market Players Density: Understanding Its Impact on Business Dynamics
The Extracorporeal Membrane Oxygenation Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Extracorporeal Membrane Oxygenation Market are:
- Terumo Group
- Medtronic Plc
- MicroPort Scientific Corporation
- LivaNova Plc
- Nipro Medical Corporation
- Eurosets S.R.L.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Extracorporeal Membrane Oxygenation Market top key players overview
Get Free Sample For